Oncology Central

Rolapitant for the treatment of chemotherapy-induced nausea and vomiting: a review of the clinical evidence

0

Chemotherapy-induced nausea and vomiting (CINV), both acute and delayed, has a dramatic effect on the well-being and quality of life of patients with cancer. Improved understanding of the mechanisms involved in CINV has led to the development of agents targeting the 5-HT3 receptor as well as the NK-1 receptor.

To view restricted content, please:
Share:

Leave A Comment